Parmax Pharma Ltd, established in November 1994, focuses on Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO) as its core business segments. Founded by Jayantilal S Dhol, Purushottam J Bhalodi, and Prabhudas D Hansalpara, the company initially specialized in manufacturing bulk drugs such as Ampicillin, Amoxycillin, Cephalexin, and Nalidixic Acid. After a brief hiatus, Parmax Pharma revitalized its operations in the pharmaceutical industry. The company set up a manufacturing plant in Hadamtala, Gujarat, equipped with a production capacity of 96 TPA, to produce and market amoxicillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate, and nalidixic acid. By May 31, 1997, the antibiotic project was fully operational, marking a significant milestone in its manufacturing capabilities. This strategic focus on APIs and CMOs positions Parmax Pharma as a key player in the pharmaceutical manufacturing sector.
